Global Hemodialysis and Peritoneal Dialysis Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

  • ID: 4516115
  • Report
  • Region: Global
  • 515 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • 3M,
  • B. Braun Melsungen AG,
  • C. R. Bard, Inc.
  • Dialifegroup,
  • Fresenius
  • JMS Co.Ltd.,
  • MORE
Global hemodialysis & peritoneal dialysis market is expected to reach USD 115,783.6 million by 2025 from USD 68,922.9 million in 2017, at a CAGR of 6.8% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as increased number of ESRD patients, increased prevalence of diabetes and hypertension, preference of patients for dialysis treatment over kidney transplant, rising geriatric population, R&D investments in for innovating dialysis products, technological advancements in the products and favourable reimbursement policies. On the other hand, risks associated with the treatment and stringent regulatory framework.

The key market players for Global hemodialysis & peritoneal dialysis market are listed below:
  • Fresenius
  • DaVita Inc.
  • Baxter,
  • B. Braun Melsungen AG,
  • Diaverum,
  • Nipro, Nxstage Medical, Inc.,
  • Nikkiso Co., Ltd.,
  • Mar Cor Purification,
  • Asahi Kasei Medical Co., Ltd,
  • Rockwell Medical,
  • Medtronic,
  • Dialifegroup,
  • JMS Co.Ltd.,
  • Atlantic Biomedical,
  • 3M,
  • Allmed Medical Care Holdings Limited.,
  • Isopure Corp.,
  • C. R. Bard, Inc.
The market is further segmented into:
  • Type
  • Products & Services
  • Modality
  • Hemodialysis Water Treatment System
  • End-user
The global hemodialysis & peritoneal dialysis market is segmented on the basis of type into hemodialysis and peritoneal dialysis. In 2018, The Hemodialysis Market is expected to dominate the market with 77.7% market share and is expected to reach USD 88,958.4 million by 2025, growing at a CAGR of 6.6% in the forecast period 2018 to 2025.

The global hemodialysis market is segmented on the basis of product services into machine, consumables, and services. In 2018, the hemodialysis machine market is expected to dominate market with 42.0% market share and is expected to reach USD 38,294.0 million by 2025, growing at a CAGR of 7.0% in the forecast period 2018 to 2025. The machines are further sub segmented into center-use hemodialysis machines and home-use hemodialysis machines. The consumables are further sub segmented into dialyzers, bloodlines, hemodialysis concentrates and others. Dialyzers are further sub-segmented on the basis of material type into synthetic and cellulose based; on the basis of flux type into high-flux and low-flux and on the basis of by hemodialysis access management products into AV fistula, arteriovenous grafts, tunneled hemodialysis catheter and temporary hemodialysis catheter. Hemodialysis concentrates are further sub-segmented into- alkaline and acidic. Services are further sub-segmented into in-center hemodialysis services and home hemodialysis services.

The global hemodialysis water treatment system Market is segmented on the basis of type into central water disinfection systems and portable water disinfection systems. In 2018, portable water disinfection systems market is expected to dominate market with 61.3% market share and is expected to reach USD 55,587.1 million by 2025, growing at a CAGR of 6.9% in the forecast period 2018 to 2025. Central water disinfection systems are further sub-segmented into chemical disinfection systems, heat disinfection systems, accessories.

The global hemodialysis market is segmented on the basis of modality into conventional long-term, short daily and nocturnal. In 2018, conventional long-term market is expected to dominate market with 42.8% market share and is expected to reach USD 39,057.9 million by 2025, growing at a CAGR of 7.0% in the forecast period 2018 to 2025.

The global peritoneal dialysis market is segmented on the basis of products and services into concentrates, machines, catheters, transfer sets, services and others. In 2018, peritoneal machine market is expected to dominate market with 32.2% market share and is expected to reach USD 9,293.5 million by 2025, growing at a CAGR of 8.5% in the forecast period 2018 to 2025. The catheters are further sub-segmented into short-term catheters and long term catheters.

The global peritoneal dialysis market is segmented on the basis of modality into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. In 2018, continuous ambulatory dialysis market is expected to dominate market with 68.3 market share and is expected to reach USD 18,576.2 million by 2025, growing at a CAGR of 7.6% in the forecast period 2018 to 2025.

The global hemodialysis & peritoneal dialysis market is segmented on the basis of end-user into hospitals, dialysis centers and home care settings. In 2018, dialysis centers market is expected to dominate market with 55.5% market share and is expected to reach USD 64,762.8 million by 2025, growing at a CAGR 6.9% in the forecast period 2018 to 2025. The home care settings are further sub-segmented into peritoneal dialysis and home dialysis.

Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Based on geography, the Global hemodialysis & peritoneal dialysis market is segmented into geographical regions, such as:
  • North- America,
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
Covered in this report

The report covers the present scenario and the growth prospects of the Global hemodialysis & peritoneal dialysis for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M,
  • B. Braun Melsungen AG,
  • C. R. Bard, Inc.
  • Dialifegroup,
  • Fresenius
  • JMS Co.Ltd.,
  • MORE
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Overview of Global Hemodialysis & Peritoneal Dialysis Market
1.4. Currency and Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Increased Number of End Stage Renal Disease (Esrd) Patients
3.1.2. Increased Prevalance of Diabetes and Hypertension
3.1.3. Preferance of Patients For Dialysis Treatment Over Kidney Transplant
3.1.4. Rising Geriatric Population
3.1.5. R&D Investemnts in For Innovating Dialysis Products
3.1.6. Technological Advancements in the Products
3.1.7. Favorable Reimbursement Policy
3.2. Restraints
3.2.1. Risks Associated With the Treatment
3.2.2. Stringent Regulatory Framework
3.3. Opportunities
3.3.1. Increased Demand of Homecare Settings For Dialysis Treatment
3.3.2. Low Cost and User Friendly Products Innovated
3.4. Challenges
3.4.1. Product Recalls

4. Executive Summary

5. Premium Insights

6. Global Hemodialysis & Peritoneal Dialysis Market, By Type
6.1. Overview
6.2. Hemodialysis
6.3. Peritoneal Dialysis

7. Global Hemodialysis Market, By Products and Services
7.1. Overview
7.2. Machines
7.2.1. Center-Use Hemodialysis Machines
7.2.2. Home-Use Hemodialysis Machines
7.3. Consumables
7.3.1. Dialyzers
7.3.1.1. Dialyzers Market, By Material Type
7.3.1.2. Dialyzers Market, By Flux Type
7.3.1.3. Hemodialysis Access Management Products Market, By Type
7.3.2. Bloodlines
7.3.3. Hemodialysis Concentrates
7.3.3.1. Alkaline
7.3.3.2. Acidic
7.3.4. Others
7.4. Services
7.4.1. In-Center Hemodialysis Services
7.4.2. Home Hemodialysis Services

8. Global Hemodialysis Market, By Modality
8.1. Overview
8.2. Conventional Long-Term
8.3. Nocturnal
8.4. Short Daily

9. Global Peritoneal Market, By Products and Services
9.1. Overview
9.2. Machines
9.3. Catheters
9.3.1. Short Term Catheters
9.3.2. Long Term Catheters
9.4. Transfer Sets
9.5. Concentrates
9.6. Services
9.7. Others

10. Global Peritoneal Dialysis Market, By Modality
10.1. Overview
10.2. Continuous Ambulatory Peritoneal Dialysis
10.3. Automated Peritoneal Dialysis

11. Global Hemodialysis Water Treatment Systems Market,
By Type
11.1. Overview
11.2. Portable Water Disinfection Systems
11.3. Central Water Disinfection Systems
11.3.1. Heat Disinfection Systems
11.3.2. Chemical Disinfection Systems
11.3.3. Accessories

12. Global Hemodialysis and Peritoneal Dialysis Market,
By End User
12.1. Overview
12.2. Dialysis Centers
12.3. Hospitals
12.4. Home Care Settings
12.4.1. Peritoneal Dialysis
12.4.2. Home Hemodialysis

13. Global Hemodialysis and Peritoneal Dialysis Market,
By Geography
13.1. Overview
13.2. North America
13.2.1. U.S.
13.2.2. Canada
13.2.3. Mexico
13.3. Europe
13.3.1. Germany
13.3.2. France
13.3.3. U.K.
13.3.4. Italy
13.3.5. Spain
13.3.6. Switzerland
13.3.7. Netherlands
13.3.8. Turkey
13.3.9. Belgium
13.3.10. Russia
13.3.11. Rest of Europe
13.4. Asia Pacific
13.4.1. Japan
13.4.2. China
13.4.3. India
13.4.4. South Korea
13.4.5. Australia
13.4.6. Singapore
13.4.7. Thailand
13.4.8. Malaysia
13.4.9. Indonesia
13.4.10. Philippines
13.4.11. Rest of Asia Pacific
13.5. South America
13.5.1. Brazil
13.5.2. Rest of South America
13.6. Middle East and Africa
13.6.1. South Africa
13.6.2. Rest of Middle East and Africa

14. Global Hemodialysis and Peritoneal Dialysis Market, Company Landscape
14.1. Company Share Analysis: Global
14.2. Company Share Analysis: North America
14.3. Company Share Analysis: Europe
14.4. Company Share Analysis: Asia-Pacific

15. Company Profile
15.1. Davita Inc.
15.1.1. Company Overview
15.1.2. Davita, Inc.: Revenue Analysis
15.1.3. Product Portfolio
15.1.4. Recent Developments
15.2. Diaverum
15.2.1. Company Overview
15.2.2. Diaverum: Company Snapshot
15.2.3. Product Portfolio
15.2.4. Recent Developments
15.3. Nipro
15.3.1. Company Overview
15.3.2. Nipro Corporation: Revenue Analysis
15.3.3. Product Portfolio
15.3.4. Recent Developments
15.4. Nxstage Medical, Inc.
15.4.1. Company Overview
15.4.2. Nxstage Medical, Inc.: Company Snapshot
15.4.3. Product Portfolio
15.4.4. Recent Developments
15.5. Nikkiso Co., Ltd.
15.5.1. Company Overview
15.5.2. Nikkiso Co., Ltd.: Revenue Analysis
15.5.3. Product Portfolio
15.5.4. Recent Developments
15.6. Atlantic Biomedical Pvt. Ltd
15.6.1. Company Overview
15.6.2. Atlantic Biomedical Pvt. Ltd: Company Snapshot
15.6.3. Product Portfolio
15.6.4. Recent Developments
15.7. 3M
15.7.1. Company Overview
15.7.2. 3M: Company Snapshot
15.7.3. Product Portfolio
15.7.4. Recent Developments
15.8. C.R. Bard Inc.
15.8.1. Company Overview
15.8.2. C. R. Bard Inc.: Revenue Analyses
15.8.3. Product Portfolio
15.8.4. Recent Developments
15.9. Allmed Medical Co., Limited
15.9.1. Company Overview
15.9.2. Allmed Medical Co., Ltd: Company Snapshot
15.9.3. Product Portfolio
15.9.4. Recent Developments
15.10. Isopure Corp.
15.10.1. Company Overview
15.10.2. Isopure Corp : Company Snapshot
15.10.3. Product Portfolio
15.10.4. Recent Developments
15.11. Cvp Medical Technology Co., Ltd
15.11.1. Company Overview
15.11.2. Cvp Medical Technology Co., Ltd.: Company Snapshot
15.11.3. Product Portfolio
15.11.4. Recent Developments
15.12. Mar Cor Purification Inc.
15.12.1. Company Overview
15.12.2. Mar Cor Purification: Company Snapshot
15.12.3. Product Portfolio
15.12.4. Recent Developments
15.13. Baxter
15.13.1. Company Overview
15.13.2. Baxter: Company Snapshot
15.13.3. Product Portfolio
15.13.4. Recent Developments
15.14. Medtronic
15.14.1. Company Overview
15.14.2. Medtronic: Rvenue Analysis
15.14.3. Product Portfolio
15.14.4. Recent Developments
15.15. Fresenius Group
15.15.1. Company Overview
15.15.2. Fresenius Group: Revenue Analysis
15.15.3. Product Portfolio
15.15.4. Recent Developments
15.16. B.Braun
15.16.1. Company Overview
15.16.2. B.Braun.: Company Snapshot
15.16.3. Product Portfolio
15.16.4. Recent Developments
15.17. Asahi Kasei Corporation
15.17.1. Company Overview
15.17.2. Asahi Kasei Corporation: Revenue Analysis
15.17.3. Product Portfolio
15.17.4. Recent Developments
15.18. Rockwell Medical, Inc.
15.18.1. Company Overview
15.18.2. Rockwell Medical, Inc.: Revenue Analysis
15.18.3. Product Portfolio
15.18.4. Recent Developments
15.19. Dialife Group
15.19.1. Company Overview
15.19.2. Dialife Group: Company Snapshot
15.19.3. Product Portfolio
15.19.4. Recent Developments
15.20. Jms Co., Ltd.
15.20.1. Company Overview
15.20.2. Jms Co., Ltd.: Company Snapshot
15.20.3. Product Portfolio
15.20.4. Recent Developments

16. Related Reports
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Fresenius
  • DaVita Inc.
  • Baxter,
  • B. Braun Melsungen AG,
  • Diaverum,
  • Nipro, Nxstage Medical, Inc.,
  • Nikkiso Co., Ltd.,
  • Mar Cor Purification,
  • Asahi Kasei Medical Co., Ltd,
  • Rockwell Medical,
  • Medtronic,
  • Dialifegroup,
  • JMS Co.Ltd.,
  • Atlantic Biomedical,
  • 3M,
  • Allmed Medical Care Holdings Limited.,
  • Isopure Corp.,
  • C. R. Bard, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll